NCM Capital Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | $482K | Sell |
1,200
-115
| -9% | -$46.2K | 1.44% | 34 |
|
|
2016
Q2 | $459K | Hold |
1,315
| – | – | 1.32% | 37 |
|
|
2016
Q1 | $474K | Hold |
1,315
| – | – | 1.37% | 38 |
|
|
2015
Q4 | $714K | Hold |
1,315
| – | – | 2.03% | 15 |
|
|
2015
Q3 | $612K | Sell |
1,315
-1,085
| -45% | -$505K | 1.81% | 18 |
|
|
2015
Q2 | $1.22M | Hold |
2,400
| – | – | 1.64% | 17 |
|
|
2015
Q1 | $1.08M | Hold |
2,400
| – | – | 1.46% | 22 |
|
|
2014
Q4 | $985K | Hold |
2,400
| – | – | 1.38% | 24 |
|
|
2014
Q3 | $865K | Sell |
2,400
-200
| -8% | -$72.1K | 1.3% | 32 |
|
|
2014
Q2 | $734K | Sell |
2,600
-300
| -10% | -$84.7K | 1.09% | 38 |
|
|
2014
Q1 | $871K | Sell |
2,900
-2,200
| -43% | -$661K | 1.37% | 28 |
|
|
2013
Q4 | $1.4M | Sell |
5,100
-2,550
| -33% | -$702K | 1.45% | 22 |
|
|
2013
Q3 | $2.39M | Sell |
7,650
-1,450
| -16% | -$454K | 2.65% | 2 |
|
|
2013
Q2 | $2.05M | Buy |
+9,100
| New | +$2.05M | 1.93% | 11 |
|